In Honor of World Hepatitis Day: Q&A with Coalition for Global Hepatitis Elimination Director John Ward, MD
Tuesday, July 28, marks World Hepatitis Day as a call to action against a preventable and curable disease that kills more than 1.3 million people …
As Pakistan enters the ‘last mile’ of polio eradication, The Task Force is supporting efforts to ensure all children in the country are immunized against
On April 16, the United Kingdom’s Department for International Development, or DFID, announced a $12.5-million grant to The Task Force’s Neglected Tropical Diseases Support Center
By Dave Ross, ScD, President and Chief Executive Officer for The Task Force for Global Health Most people in the world do not have access
“Data is power.” That was the message that The Task Force and its trachoma elimination partners brought to technology leaders during a March 11 panel
Key stakeholders in the global fight to eliminate intestinal worms as a public health problem will now emphasize measuring disease levels to track program impact.
By Genevieve LaCon, MPH, senior program associate, International Trachoma Initiative, The Task Force for Global Health Six months into my position at The Task Force’s
Maria Rebollo Polo, MD, MPH, former director of programs for The Task Force’s Neglected Tropical Diseases (NTD) Support Center, has been named team leader for
A new smartphone-based data platform called Tropical Data is helping 13 countries in Africa, Asia, and Latin America track their progress towards the elimination of
A new web-based tool developed by The Task Force and partners has significantly reduced turnover of healthcare workers in Mozambique and brought greater stability to
GSK Chief Executive Officer (CEO) Sir Andrew Witty is one of the pharmaceutical industry’s most passionate advocates for increasing access to essential medicines and vaccines
The Task Force is facilitating clinical trials for a promising new treatment to combat a disfiguring disease known as elephantiasis, which can result from infection
The Task Force is supporting the development of two new polio antiviral therapies to treat immune-deficient people who excrete poliovirus after receiving oral polio vaccine
Header photo caption: A drug distributor travels long distances to a remote village in Cameroon to get medicines for onchocerciasis (river blindness) and lymphatic filariasis to marginalized societies most in need.